NRX Pharmaceuticals Files 8-K Report
Ticker: NRXPW · Form: 8-K · Filed: Jun 9, 2025 · CIK: 1719406
| Field | Detail |
|---|---|
| Company | Nrx Pharmaceuticals, INC. (NRXPW) |
| Form Type | 8-K |
| Filed Date | Jun 9, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-filing, 8-K, financials
Related Tickers: NRXP
TL;DR
NRXP filed an 8-K on June 9th for events on June 5th. Standard corporate update.
AI Summary
On June 5, 2025, NRX Pharmaceuticals, Inc. filed an 8-K report detailing other events and financial statements. The company, formerly known as Big Rock Partners Acquisition Corp., is incorporated in Delaware and its fiscal year ends on December 31st. The filing was made on June 9, 2025.
Why It Matters
This filing provides an update on NRX Pharmaceuticals' corporate activities and financial reporting, which is crucial for investors to stay informed about the company's status.
Risk Assessment
Risk Level: low — This filing is a routine 8-K report for other events and financial statements, not indicating any immediate significant risks.
Key Numbers
- 001-38302 — Commission File Number (Identifies the company's SEC filing history)
- 82-2844431 — IRS Employer Identification No. (Company's tax identification number)
Key Players & Entities
- NRX Pharmaceuticals, Inc. (company) — Registrant
- Big Rock Partners Acquisition Corp. (company) — Former company name
- June 5, 2025 (date) — Date of earliest event reported
- June 9, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
FAQ
What specific 'Other Events' are detailed in this 8-K filing?
The provided text does not specify the 'Other Events', only that it is an item reported in the 8-K.
What is the significance of the former company name 'Big Rock Partners Acquisition Corp.'?
NRX Pharmaceuticals, Inc. was formerly known as Big Rock Partners Acquisition Corp., indicating a name change occurred on October 12, 2017.
When was NRX Pharmaceuticals, Inc. incorporated and in which state?
NRX Pharmaceuticals, Inc. was incorporated in Delaware.
What is the standard industrial classification for NRX Pharmaceuticals, Inc.?
The Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
What is the business address of NRX Pharmaceuticals, Inc. as listed in the filing?
The business address is 1201 Orange Street, Suite 600, Wilmington, Delaware 19801.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 9, 2025 regarding NRX Pharmaceuticals, Inc. (NRXPW).